Sagewood Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
7,717
+1,752
+29% +$377K 0.44% 34
2026
Q1
$1.3M Buy
5,965
+1,018
+21% +$226K 0.41% 43
2025
Q4
$1.13M Buy
+4,947
New +$1.13M 0.4% 42

Other funds holding ABBV

Sagewood Asset Management's ABBV Position: Q2 2026 in Review

Sagewood Asset Management increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $377K and bringing the position to 7,717 shares worth $1.94M. The position accounts for 0.44% of the portfolio, ranked #34.

Sagewood Asset Management first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sagewood Asset Management held 7,717 shares of AbbVie worth $1.94M as of Q2 2026.
  • Sagewood Asset Management bought 1,752 AbbVie shares in Q2 2026, an estimated $377K.
  • AbbVie made up 0.44% of Sagewood Asset Management's portfolio in Q2 2026, its #34 holding.
  • Sagewood Asset Management first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.